 |
HebeCell
Last updated: May 05, 2024
John Lu - President and CEO
Country: USA | Funding: $63M (+)
Website: https://hebecellcorp.com/
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.
Website: https://hebecellcorp.com/
HebeCell develops and commercializes cell-based therapeutics to treat incurable diseases. It produces cancer-specific natural killer (NK) cells that are developing while suspended in a liquid solution within a bioreactor, allowing them to reproduce indefinitely.
